Chr. Hansen - Page 1 | WholeFoods Magazine

Westin Cape Coral Resort at Marina Village

Organic & Natural Health Gears Up for 10th Anniversary Conference

The event will feature transformative discussions with industry leaders.

January 4, 2024

The Organic & Natural Health Association (O&N Health) conference is designed to optimize networking opportunities while engaging in deep and meaningful discussions on issues facing the natural products industry and the consumers it serves.

M&A Update: Novozymes and Chr. Hansen

December 27, 2022

Maggie Jaqua, Content Director

Copenhagen, Denmark—Novozymes A/S and Chr. Hansen Holding A/S have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combined group will be equipped to address global challenges including enabling healthier lives, transforming food systems, and accelerating towards a climate neutral society, according...

Chr. Hansen to Sell its Natural Colors Business

October 6, 2020

WholeFoods Magazine Staff

Hoersholm, Denmark—Chr. Hanson is selling its Natural Colors business to EQT IX, a global investment organization, for EUR 800 million, according to a press release. Natural Colors serves over 1,600 customers in the food and beverages industry, the press release says. It employs approximately 650 people and has grown by...

Chr. Hansen Acquires UAS Labs

June 18, 2020

WholeFoods Magazine Staff

Chr. Hansen Holding A/S announced that it has entered into an agreement with the owners of UAS Laboratories LLC to acquire 100% of the company for $530 million. The acquisition will further strengthen and expand Chr. Hansen’s global microbial platform and Human Health business, according to the announcement, and is...

Chr. Hansen, Lonza's Joint Venture BacThera Receives Anti-Trust Approvals

August 29, 2019

WholeFoods Magazine Staff

Copenhagen, Denmark and Basel, Switzerland–Chr. Hansen Holding A/S and Lonza AG announced that they have received the necessary approvals from anti-trust regulators to establish BacThera--a 50/50 joint venture in the emerging market for live biotherapeutic products. BacThera will be headquartered in Basel, Switzerland, and is now engaging with its first...

Lonza, Chr. Hansen in Joint Venture to Create Live Biotherapeutic Products

April 3, 2019

WholeFoods Magazine Staff

Copenhagen, Denmark, and Basel, Switzerland—Lonza, a pharma contract manufacturing company, and Chr. Hansen, a bioscience company, are teaming up for a joint venture in the development and manufacturing of live biotherapeutic products for pharma and biotech customers, according to a press release. The release says that the companies are creating...